The Effect of Tecar Therapy on Peripheral Neuropathy in Patients with Type II Diabetes

Phase 3

• Conditions: Type II Diabetes.; E11.4; Type 2 diabetes mellitus with neurological complications

• Registration Number: IRCT20190726044337N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Age: 18-75
The least duration of illness affliction was more than six months
Patients have type II diabetes Mellitus with signs and Symtoms of mild(I) to moderate(II) Peripheral Neuropathy
Pain Intensity which was based on VAS (Visual Analog Scale) scores were more than three

Exclusion Criteria

Pregnancy
Diabetic Infectious Wound
Involvement of Cardiovascular system
Involvement of Respiratory system
To have Pace maker

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intensity of pain. Timepoint: Before treatment, after ten session, Follow up for six weeks. Method of measurement: Base on visual analogue scale.

Secondary Outcome Measures

Name	Time	Method
Tactile sensation of feet. Timepoint: Before treatment, After ten session, Follow up for six weeks. Method of measurement: Monofilament 5.07/10 g.